Structural Formula (Image 01)
Chemical structure diagram of Gabapentin showing a cyclohexane ring with attached amino and carboxyethyl groups.*
Gabapentin
Product Images NDC 50436-7286
7 FDA label images from Unit Dose Services · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50436-7286). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Image 02)
A line graph showing mean pain score over an 8-week period for Gabapentin 3600 mg/day versus placebo. The x-axis represents weeks, divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores, with Gabapentin scores decreasing notably compared to placebo.*
Figure 2 (Image 03)
A line graph showing mean pain scores over 7 weeks comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The timeline is divided into a 3-week dose titration period and a 4-week fixed dose period. Gabapentin doses show a decrease in mean pain score compared to placebo throughout the study.*
Figure 3 (Image 04)
A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' displays the percentage of responders in two separate studies. Study 1 compares placebo (PBO) at 12% with Gabapentin (GBP) 3600 mg at 29%. Study 2 compares placebo (PBO) at 14% with Gabapentin 1800 mg at 32% and Gabapentin 2400 mg at 34%. Statistical significance is indicated with p-values less than 0.01 and 0.001.*
Figure 4 (Image 05)
A scatter plot depicting percentage difference versus daily dose (mg) for Gabapentin from three studies labeled a, b, and c. The x-axis shows daily doses of 600, 900, 1200, and 1800 mg, and the y-axis shows difference percentages ranging from 2% to 22%. Each study is represented by a distinct marker and letter code, with data points distributed across the dose range.*
Equation (Image 08)
The image shows a pharmacokinetic formula used to calculate creatinine clearance (CLCr). It includes variables for age in years, weight in kilograms, serum creatinine in mg/dL, with an adjustment factor of 0.85 for female patients.*
Label Image (Lbl504367286)
Label for Gabapentin 800 mg tablets, containing 90 tablets. The label shows the NDC number 50436-7286-3 and states the product is packaged by Unit Dose Services, LLC, Miami, FL. It includes storage instructions to keep the medication out of reach of children and store at controlled room temperature. Manufacturer details list Teva as the manufacturer.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
